Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: FASEB J. 2022 May;36(5):e22328. doi: 10.1096/fj.202200251R

Table 1.

Histological analysis of pulmonary pathology with IL-4 treatment

Treatment Airway damage Leukocytic interstitial infiltrates Marginating intravascular segmented neutrophilia (>3 in medium vessels) Intravascular blasts Peribronchiolar/peri vascular leukemia infiltration Leukemia alveolar septal involvement Leukemia (0 or 1, E=equivocal)
Vehicle #1 0 0 0 0 0 0 0
Vehicle #2 0 1 0 1 0 0 1
Vehicle #3 0 1 1 1 0 0 1
Vehicle #4 0 0 0 1 0 0 1
IL-4 #1 0 1 1 1 1 1 1
IL-4 #2 0 1 1 E 0 0 E
IL-4 #3 0 1 1 0 0 0 0
IL-4 #4 0 1 1 0 0 0 0

0=absent, 1=present

Lung sections from IL-4 treated mice (n=4) and their counterparts (n=4) were stained with H&E dye. A blinded histological analysis was performed on the sections to score the pulmonary inflammation and leukemia infiltration.